Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Landstar (LSTR) Stock Down On Q4 Earnings Miss, Y/Y Decline

Published 01/30/2020, 02:47 AM
Updated 07/09/2023, 06:31 AM

Landstar System’s (NASDAQ:LSTR) fourth-quarter 2019 earnings of $1.27 per share missed the Zacks Consensus Estimate by 14 cents. Moreover, the bottom line declined 24.4% on a year-over-year basis, mainly due to lower revenues. Notably, revenues dipped 15.9% on a year-over-year basis to $994.9 million.

The top-line figure, however, surpassed the Zacks Consensus Estimate of $992.5 million. The lackluster bottom-line performance and the year-over-revenue decline resulted in the stock shedding 12.9% of its value in after-market trading on Jan 29.

Lower truck volumes and unfavorable pricing dented truck revenues, mainly due to unfavorable market conditions, thereby hurting results. Gross profit (revenues excluding the cost of purchased transportation and commissions to agents) came in at $148.68 million in the reported quarter, down 12% year over year.

Further, operating margin (operating income divided by gross profit) dipped to 44.7% from the prior year’s 51%. Total costs and expenses (on a reported basis) declined to $929.7 million from the $1.09 billion incurred in the prior-year period.

Total revenues in the truck transportation segment — accounting for bulk (91.7%) of the top line — were $911.8 million, down 15.4%. Within the truck transportation segment, truckload transportation revenue hauled via van equipment in the reported quarter fell 18.9% to $571.77 million. Also, truckload transportation revenue hauled via unsided/platform equipment decreased 9.1% to $315.2 million.

Less-than-truckload revenues went down 4.7% to $24.85 million. The overall fourth-quarter truck revenue per load too dropped 9.2% on a year-over-year basis.

Rail intermodal revenues of $30.75 million fell 6.7%. Moreover, revenues in the ocean and air cargo carriers segment plunged 37.9% to $32.22 million. Meanwhile, other revenues increased to $20.1 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

At the end of 2019, this Zacks Rank #4 (Sell) company’s cash and cash equivalents were $319.51 million compared with the $199.74 million recorded at the end of December 2018. Additionally, long-term debt (excluding current maturities) totaled $70.21 million compared with $84.86 million at the end of 2018. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Landstar rewarded its shareholders with $116.46 million through dividends ($27.89 million) and buybacks ($88.57 million) in 2019. The company generated free cash flow of $288.42 million in the year.

Landstar System, Inc. Price, Consensus and EPS Surprise

Landstar System, Inc. price-consensus-eps-surprise-chart | Landstar System, Inc. Quote

Q1 Guidance

The company expects revenues between $915 million and $965 million for the March-end quarter. Management expects current-quarter earnings per share in the $1.10-$1.20 range (excluding the resolution of a fatal accident that occurred in January). The Zacks Consensus Estimate for first-quarter 2020 earnings per share and revenues is pegged at $1.34 and $941.18 million, respectively.

Upcoming Releases

Investors interested in the broader Transportation sector await fourth-quarter 2019 earnings reports from key players like Air Lease Corp. (NYSE:AL) , Expeditors International of Washington (NASDAQ:EXPD) and Hertz Global Holdings (NYSE:HTZ) .

Air Lease and Expeditors will announce results on Feb 14 and Feb 18, respectively. Hertz will release fourth-quarter earnings numbers on Feb 24.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Air Lease Corporation (AL): Free Stock Analysis Report

Expeditors International of Washington, Inc. (EXPD): Free Stock Analysis Report

Landstar System, Inc. (LSTR): Free Stock Analysis Report

Hertz Global Holdings, Inc (HTZ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.